Dr. Jorge Chaves, MD
Claim this profileNorthwest Medical Specialties
Studies Cancer
Studies Melanoma
9 reported clinical trials
26 drugs studied
Area of expertise
1Cancer
HER2 positive
Stage IV
Stage III
2Melanoma
Stage IV
Stage III
PD-L1 positive
Affiliated Hospitals
Clinical Trials Jorge Chaves, MD is currently running
Ruxolitinib + Steroids + Lenalidomide
for Multiple Myeloma
This trial tests a combination of ruxolitinib, steroids, and lenalidomide in multiple myeloma patients who are not responding to current treatments. The drugs work together to block cancer growth signals, reduce inflammation, and enhance the immune response. Lenalidomide is an immunomodulatory drug developed from thalidomide, effective in multiple myeloma and approved by the FDA.
Recruiting1 award Phase 113 criteria
NEO212
for Brain Tumors
This multi-site, Phase 1/2 clinical trial is an open-label study to identify the safety, pharmacokinetics, and efficacy of a repeated dose regimen of NEO212 for the treatment of patients with radiographically-confirmed progression of Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype, and the safety, pharmacokinetics and efficacy of a repeated dose regimen of NEO212 when given with select SOC for the treatment of solid tumor patients with radiographically confirmed uncontrolled brain metastasis. The study will have three phases, Phase 1, Phase 2a and Phase 2b.
Recruiting1 award Phase 1 & 210 criteria
More about Jorge Chaves, MD
Clinical Trial Related7 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Jorge Chaves, MD has experience with
- Pembrolizumab
- Paclitaxel
- Ruxolitinib
- Lenalidomide
- Methylprednisolone
- KIN-2787
Breakdown of trials Jorge Chaves, MD has run
Cancer
Melanoma
Solid Tumors
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jorge Chaves, MD specialize in?
Jorge Chaves, MD focuses on Cancer and Melanoma. In particular, much of their work with Cancer has involved HER2 positive patients, or patients who are Stage IV.
Is Jorge Chaves, MD currently recruiting for clinical trials?
Yes, Jorge Chaves, MD is currently recruiting for 2 clinical trials in Tacoma Washington. If you're interested in participating, you should apply.
Are there any treatments that Jorge Chaves, MD has studied deeply?
Yes, Jorge Chaves, MD has studied treatments such as Pembrolizumab, Paclitaxel, Ruxolitinib.
What is the best way to schedule an appointment with Jorge Chaves, MD?
Apply for one of the trials that Jorge Chaves, MD is conducting.
What is the office address of Jorge Chaves, MD?
The office of Jorge Chaves, MD is located at: Northwest Medical Specialties, Tacoma, Washington 98405 United States. This is the address for their practice at the Northwest Medical Specialties.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.